Overview of Protein Aggregation in Single, Double, and Triple Neurodegenerative Brain Amyloidoses

NeuroMolecular Medicine

Volumn 4, Issue 1-2, 2003, Pages 1-5

  Trojanowski, John Q ^a   Mattson, Mark P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; CELL NUCLEUS INCLUSION BODY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DOWN SYNDROME; HUMAN; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; REVIEW; SHY DRAGER SYNDROME;

AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; MUTATION; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; SYNUCLEINS; TAU PROTEINS;

EID: 0142200946     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:4:1-2:1     Document Type: Review

References (24)

1. Auluck P. K. and Bonini N. M. (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med. 8, 1185-1186.
2. Auluck P. K., Chan H. Y. E., Trojanowski J. Q., Lee V. M.-Y., and Bonini N. M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model of Parkinson's disease. Science 295, 865-868.
3. Bonini N. M. (2002) Chaperoning brain degeneration. Proc. Natl. Acad. Sci. USA 99, 16407-16411.
4. Bucciantini M., Giannoni E., Chiti F., et al. (2002) Inherent toxicity of aggregates implies a common mechanism of protein misfolding disease. Nature 416, 507-511.
5. Giasson B. I., Forman M. S., Higuchi M., et al. (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 300, 636-639.
6. Giasson B. I., Lee V. M.-Y., Ischiropoulos H., and Trojanowski J. Q. (2002a) The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's disease. Free Radic. Biol. Med. 32, 1264-1275.
7. Giasson B. I., Duda J. E., Murray I. V., et al. (2002b) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290, 985-989.
8. Hardy J., Duff K., Hardy K. G., Perez-Tur J., and Hutton M. (1998) Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat. Neurosci. 1, 355-358.
9. Hardy J. (1997) Amyloid the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
10. Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmcol. Sci. 12, 383-388.
11. Irizarry M. C. and Hyman B. T. Alzheimer disease therapeutics. (2001) J. Neuropath. Exp. Neurol. 60, 923-928.
12. Lee V. M.-Y., Goedert M., and Trojanowski J. Q. (2001) generative tauopathies. Annu. Rev. Neurosci. 24, 21-1159.
13. Loo T. W. and Clarke D. M. (2003) Application of chemical chaperones to the rescue of folding defects. Methods Mol. Biol. 232, 231-244.
14. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 20, 154-159.
15. Mattson M. P. (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol. Med., 3, 65-94.
16. Mattson M. P., Chan S. L., and Duan W. (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 82, 637-672.
17. Mayeux R. and Sano M. (1999) Treatment of Alzheimer's disease. N. Engl. J. Med. 341, 1670-1679.
18. Mudher A. and Lovestone S. (2002) Alzheimer's disease-do tauists and Baptists finally shake hands? Trends Neurosci. 25, 22-26.
19. Soto C. (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49-60.
20. Taylor J. P., Hardy J., and Fischbeck K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991-1995.
21. Trojanowski J. Q. and Lee V. M-Y. (2003) Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses. Ann. NY Acad. Sci. 991, 107-111.
22. Welch W. J. and Gambetti P. (1998) Chaperoning brain diseases. Nature 392, 23-24.
23. Trojanowski J. Q. (2002) Emerging Alzheimer's disease therapies: focusing on the future. Neurobiol Aging 23, 985-990.
24. Trojanowski J. Q. and Lee V. M.-Y. (2000) "Fatal attractions" of proteins: a comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. N Y Acad. Sci. 924, 62-67.